Rankings
▼
Calendar
MDGL Q4 2016 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MDGL
Madrigal Pharmaceuticals, Inc.
$10B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-0.67
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$576,235
Balance Sheet
Total Assets
$41M
Total Liabilities
$5M
Stockholders' Equity
$36M
Cash & Equivalents
$40M
← FY 2016
All Quarters
Q1 2017 →
